Report NJ

Novo Can't Get 'Deceptive' Lilly GLP-1 Ads Blocked Amid Suit

Report from the legal press · reported by 4 publishers

Headline as published by Law360 Life Sciences on Oct 26, 2026; collected by the wire Oct 27, 2026, 1:31 AM ET.

Read at Law360 Life Sciences

Coverage

  1. Law360 Life Sciences Legal press

    Novo Can't Get 'Deceptive' Lilly GLP-1 Ads Blocked Amid Suit

  2. Law360 Health Legal press

    Novo Can't Get 'Deceptive' Lilly GLP-1 Ads Blocked Amid Suit

  3. Law360 Consumer Protection Legal press

    Novo Can't Get 'Deceptive' Lilly GLP-1 Ads Blocked Amid Suit

  4. Law360 New Jersey Legal press

    Novo Can't Get 'Deceptive' Lilly GLP-1 Ads Blocked Amid Suit

Named in this story

Topics

Explore the named firms, organizations and MDL dockets above. Sources and method

MDL No. 3094

GLP-1 Receptor Agonists

IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation

Transferee judge
Karen S. Marston
Court
Eastern District of Pennsylvania
Actions pending
4,025

Per the JPML pending-dockets report of October 1, 2026.